Classic Lectures in Pathology: What You Need to Know: Lung Pathology – A Video CME Teaching Activity
- Describe the essential elements of diagnosing non-small cell lung carcinoma in the molecular era.
- Discuss the new WHO classification of lung tumors.
- Employ a diagnostic approach to interstitial lung diseases.
- Discuss the WHO adenocarcinoma classification and implications for selection of targeted therapies.
- Discuss pulmonary manifestations of autoimmune disease.
- Apply a more practical approach to technical issues in processing of pulmonary pathology specimens.
- Describe the life cycle of diffuse alveolar damage.
- Recognize and assess granulomatous disease of the lung.
- Explain adenocarcinoma of the lung.
- Differentiate neoplastic and inflammatory lung disease.
- Recognize, assess and diagnose lung and pleura borderline tumors and cancer more easily.
- Utilize immunohistochemistry in mesothelioma.
Session 1
Benign-borderline Lung Tumors
Mark R. Wick, M.D.
Early Lung Carcinoma and Metastasis
Mark R. Wick, M.D.
Mesothelioma IHC2
Mark R. Wick, M.D.
Session 2
Approach to Pulmonary Pathology Using Clinical, Radiological, and Pathological Correlation
Kevin O. Leslie, M.D.
Guide to the WHO Adenocarcinoma Classification and Implications for Selection of Targeted Therapies
Kevin O. Leslie, M.D.
Session 3
Technical Issues in the Processing of Lung Samples
Kevin O. Leslie, M.D.
Acute Lung Injury “One Ring to Rule Them All”
Kevin O. Leslie, M.D.
The Pulmonary Pathology of Rheumatic Diseases
Kevin O. Leslie, M.D.
Usual Interstitial Pneumonia of Idiopathic Pulmonary Fibrosis and its Mimics – Case Based
Maxwell L. Smith, M.D.
Session 4
Molecular Pathology of Lung Cancer – Case Based
Maxwell L. Smith, M.D.
Granulomatous Disease of the Lung – Case Based
Kevin O. Leslie, M.D.
Approach to Diffuse Alveolar Hemorrhage (DAH) and Pulmonary Vasculitis
Kevin O. Leslie, M.D.
Case Studies in Pulmonary Pathology 10 Diagnostic Vignettes …you should know
Kevin O. Leslie, M.D.
Session 5
Neoplastic Lung Disease – Case Based
Kevin O. Leslie, M.D.
Practical Approach to Pulmonary Fibrosis
Kevin O. Leslie, M.D.
Diagnosing Non-Small Cell Lung Carcinoma in the Molecular Age: Doing More With Less
Carol Farver, M.D.
Session 6
What’s New in the World Health Organization Classification of Lung Tumors
Carol Farver, M.D.
Interstitial Lung Pathology: What Every Pathologist Needs to Know
Carol Farver, M.D.
Reviews
There are no reviews yet.